Genetic basis of metabolic abnormalities in polycystic ovary syndrome: implications for therapy.

Belén Roldán, José L San Millán, Héctor F Escobar-Morreale
{"title":"Genetic basis of metabolic abnormalities in polycystic ovary syndrome: implications for therapy.","authors":"Belén Roldán,&nbsp;José L San Millán,&nbsp;Héctor F Escobar-Morreale","doi":"10.2165/00129785-200404020-00004","DOIUrl":null,"url":null,"abstract":"<p><p>Polycystic ovary syndrome (PCOS) is a common heterogeneous disorder characterized by hyperandrogenism and chronic anovulation. The syndrome is frequently associated with an increased risk for insulin resistance and type 2 diabetes mellitus; obesity exacerbates insulin resistance and favors the progression from impaired glucose tolerance to diabetes in these patients. In young women, precocious pubarche and hyperinsulinemia are early manifestations of PCOS. The familial clustering of women with PCOS suggests that heredity is implicated in the origin of the syndrome. However, genetic approaches to its pathogenesis have been hampered by the heterogeneity of phenotypic features within families, and the lack of uniform criteria for diagnosis. Currently, PCOS is considered a polygenic trait that might result from the interaction of susceptibility and protective genomic variants under the influence of environmental factors. Both linkage analysis and association studies are valid tools for the study of the genetics of PCOS. Candidate genes for PCOS include those related to androgenic pathways and metabolic associations of the syndrome. More recently, genes encoding inflammatory cytokines have been identified as target genes for PCOS, as proinflammatory genotypes and phenotypes are also associated with obesity, insulin resistance, type 2 diabetes, PCOS, and increased cardiovascular risk. This paper reviews the candidate genes involved in the metabolic pathways that are altered in patients with PCOS. Despite a significant amount of research in this area, none of the genes studied so far has been identified as the PCOS susceptibility gene for the majority of cases. PCOS is the first component of the metabolic syndrome to be detected in many women, so the identification and correct diagnosis of PCOS has important preventive and therapeutic implications for the affected women and their families. In the future, new therapeutic approaches to PCOS will rely on knowing the genes, environmental influences, and etiologic mechanisms associated with the disorder.</p>","PeriodicalId":72171,"journal":{"name":"American journal of pharmacogenomics : genomics-related research in drug development and clinical practice","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2004-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2165/00129785-200404020-00004","citationCount":"42","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of pharmacogenomics : genomics-related research in drug development and clinical practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2165/00129785-200404020-00004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 42

Abstract

Polycystic ovary syndrome (PCOS) is a common heterogeneous disorder characterized by hyperandrogenism and chronic anovulation. The syndrome is frequently associated with an increased risk for insulin resistance and type 2 diabetes mellitus; obesity exacerbates insulin resistance and favors the progression from impaired glucose tolerance to diabetes in these patients. In young women, precocious pubarche and hyperinsulinemia are early manifestations of PCOS. The familial clustering of women with PCOS suggests that heredity is implicated in the origin of the syndrome. However, genetic approaches to its pathogenesis have been hampered by the heterogeneity of phenotypic features within families, and the lack of uniform criteria for diagnosis. Currently, PCOS is considered a polygenic trait that might result from the interaction of susceptibility and protective genomic variants under the influence of environmental factors. Both linkage analysis and association studies are valid tools for the study of the genetics of PCOS. Candidate genes for PCOS include those related to androgenic pathways and metabolic associations of the syndrome. More recently, genes encoding inflammatory cytokines have been identified as target genes for PCOS, as proinflammatory genotypes and phenotypes are also associated with obesity, insulin resistance, type 2 diabetes, PCOS, and increased cardiovascular risk. This paper reviews the candidate genes involved in the metabolic pathways that are altered in patients with PCOS. Despite a significant amount of research in this area, none of the genes studied so far has been identified as the PCOS susceptibility gene for the majority of cases. PCOS is the first component of the metabolic syndrome to be detected in many women, so the identification and correct diagnosis of PCOS has important preventive and therapeutic implications for the affected women and their families. In the future, new therapeutic approaches to PCOS will rely on knowing the genes, environmental influences, and etiologic mechanisms associated with the disorder.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
多囊卵巢综合征代谢异常的遗传基础:对治疗的影响。
多囊卵巢综合征(PCOS)是一种常见的异质性疾病,以高雄激素和慢性无排卵为特征。该综合征通常与胰岛素抵抗和2型糖尿病的风险增加有关;肥胖加重胰岛素抵抗,有利于这些患者从糖耐量受损发展为糖尿病。在年轻女性中,青春期早熟和高胰岛素血症是多囊卵巢综合征的早期表现。女性多囊卵巢综合征的家族聚类表明遗传与该综合征的起源有关。然而,由于家族内表型特征的异质性和缺乏统一的诊断标准,其发病机制的遗传方法受到阻碍。目前认为多囊卵巢综合征是一种多基因性状,可能是易感性和保护性基因组变异在环境因素影响下相互作用的结果。连锁分析和关联研究是多囊卵巢综合征遗传学研究的有效工具。多囊卵巢综合征的候选基因包括那些与雄激素途径和代谢相关的综合征。最近,编码炎性细胞因子的基因已被确定为多囊卵巢综合征的靶基因,因为促炎基因型和表型也与肥胖、胰岛素抵抗、2型糖尿病、多囊卵巢综合征和心血管风险增加有关。本文综述了参与多囊卵巢综合征患者代谢途径改变的候选基因。尽管在这一领域进行了大量的研究,但迄今为止所研究的基因中没有一个被确定为大多数多囊卵巢综合征的易感基因。PCOS是许多女性代谢综合征的第一个被检测到的组成部分,因此PCOS的识别和正确诊断对患病女性及其家庭具有重要的预防和治疗意义。在未来,新的多囊卵巢综合征的治疗方法将依赖于了解与该疾病相关的基因、环境影响和病因机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Towards molecular medicine: a case for a biological periodic table. Genetic testing in Crohn disease: utility in individualizing patient management. Identifying DNA methylation biomarkers of cancer drug response. The Autism Genome Project: goals and strategies. Oncogenes as novel targets for cancer therapy (part II): Intermediate signaling molecules.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1